PPARA and metabolic dysfunction-associated steatohepatitis: Our study has demonstrated that the decreased mRNA and protein expression of hepatic PPAR-α in MCD-induced NASH mice could be significantly upregulated after PEA treatment, suggesting that PEA may promote fatty acid β-oxidation through the PPAR-α signaling pathway.